| 961/1816 | US=28 / Biol/Mol Eder JP, Zuckerman DS. Endpoints for the determination of efficacy of antiangiogenic agents in clinical trials. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 509-24. ISBN 978-1-58829-870-6. |
| 962/1816 | US=28 / Biol/Mol Clamp AR, Jayson GC. The role of imaging in the clinical development of antiangiogenic agents. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 525-36. ISBN 978-1-58829-870-6. ANGIOGENESE; ENSAIOS CLINICOS; IMAGEM; ANTIANGIOGENICS; DCE-RM; PET; CT FUNCIONAL; ULTRA-SOM |
| 963/1816 | US=28 / Urologia Hugec V, Dutcher JP. Management of patients with pathologic variants of renal cell carcinoma: papillary, collecting duct, medullary and chromophobe carcinoma, and sarcomatoid differentiation. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 529-44. ISBN 978-1-58829-251-3. CARCINOMA DE CELULAS RENAIS; PAPILARES; COLETA DE DUTO; CARCINOMA MEDULAR; CROMOFOBO; SARCOMATOIDE |
| 964/1816 | US=28 / Urologia Rabets JC, Goldfarb DA. Renal cell carcinoma in patients with end-stage renal diseases. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 545-53. ISBN 978-1-58829-251-3. CARCINOMA DE CELULAS RENAIS; PACIENTES EM ESTAGIO FINAL DE DOENCAS RENAIS; DRCA; CARCINOMA DE CELULAS RENAIS |
| 965/1816 | US=28 / Urologia Frank I, Blute ML. Management of renal adenomas and oncocytomas. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 555-63. ISBN 978-1-58829-251-3. GESTAO DE ADENOMAS RENAIS E ONCOCITOMA; ADENOMAS RENAIS; ONCOCITOMA; PAPILAR ADENOMA; METANEFRICO ADENOMA |
| 966/1816 | US=28 / Urologia Martin SF, Tamboli P, Wood CG. Renal angiomyolipoma: diagnosis and management. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 565-86. ISBN 978-1-58829-251-3. ANGIOMIOLIPOMA RENAL. DIAGNOSTICO; ANGIOMIOLIPOMA RENAL. TRATAMENTO; ANGIOMIOLIPOMA RENAL; EPITELIOIDE ANGIOMIOLIPOMA; ANGIOEMBOLIZATION |
| 967/1816 | US=28 / Urologia Garcia JA, Dreiche R. Transitional cell carcinoma of the renal pelvis:. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 565-86. ISBN 978-1-58829-251-3. ANGIOMIOLIPOMA RENAL. DIAGNOSTICO; ANGIOMIOLIPOMA RENAL. TRATAMENTO; ANGIOMIOLIPOMA RENAL; EPITELIOIDE ANGIOMIOLIPOMA; ANGIOEMBOLIZATION |
| 968/1816 | US=28 / Urologia Ross JH. Wilms' tumor in children and adults. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 599-616. ISBN 978-1-58829-251-3. TUMOR DE WILMS EM CRIANCAS; TUMOR DE WILMS EM ADULTOS; TUMOR DE WILMS EM CRIANCAS. TERAPIA ADJUVANTE; TUMOR DE WILMS EM ADULTOS. TERAPIA ADJUVANTE |
| 969/1816 | US=28 / Urologia Novakovic KR, Campbell SC. Rare malignancies of the kidney: evaluation and management. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 617-36. ISBN 978-1-58829-251-3. NEOPLASIAS MALIGNAS RARAS DO RIM; SARCOMA RENAL; LINFOMA RENAL; CARCINOMA; TUMOR NEUROECTODERMICO PRIMITIVO; CARCINOMA DE CELULAS PEQUENAS |
| 970/1816 | US=35 / Clín/Medica Harvey RA, Champe PC, Fisher BD. Retrovírus e AIDS. In: ___. Microbiologia ilustrada. 2 ed. Porto Alegre: Artmed, 2008. p. 293-308. ISBN 85-3631105-0. RETROVIRUS; AIDS; FAMILIA RETROVIRIDAE; VIRUS DA IMUNODEFICIENCIA HUMANA; VIRUS LINFOTROFICOS TIPOS 1; VIRUS LINFOTROFICOS TIPOS 2; CELULAS T HUMANA |
| 971/1816 | US=35-A / Ginecologia Soper DE. Infecções geniturinárias e doenças sexualmente transmitidas. In: Berek JS. Berek & Novak: tratado de ginecologia. 14ª ed. Rio de Janeiro: Guanabara-Koogan, 2008. p. 404-16. ISBN 85-2771439-6. INFECCOES GENITURINARIAS; DOENCAS SEXUALMENTE TRANSMITIDAS; VAGINA NORMAL; INFECCOES VAGINAIS; CANDIDIASE VULVOVAGINAL; VAGINITE INFLAMATORIA; VAGINITE ATROFICA; CERVICITE; DOENCAS INFLAMATORIAS PELVICAS; ULCERA GENITAL; VERRUGAS GENITAIS; HIV; VIRUS DA IMUNODEFICIENCIA HUMANA; CISTITE AGUDA; CISTITE RECORRENTE; URETRITE; PIELONEFRITE AGUDA |
| 972/1816 | US=21 / Enfermagem Rêgo MMS, Monteiro MLG. Qualidade na prática de enfermagem em terapia intensiva. In: Santoro D, Molinaro LC, Behring LPB, Monteiro MLG, Silva RCL. Cuidados de enfermagem em terapia intensiva: recomendações. Rio de Janeiro: Águia Dourada, 2008. p. 51-62. ISBN 85-88656-17-8. TERAPIA INTENSIVA; QUALIDADE NA ENFERMAGEM; GESTAO DA QUALIDADE; INTERACAO HUMANA; PREVENCAO; INTEGRACAO; EDUCACAO; PROMOCAO DE CUIDADOS INTENSIVOS; INFORMACAO; PROCESSO ORGANIZACIONAL |
| 973/1816 | US=38 / Biol/Mol O'Gorman MRG. Guidelines for the use of flow cytometry in the management of patientes infected with the human immunodeficiency virus type-1 and the acquired immuno deficiency syndrome. In: O'Gorman MRG, Donnenbeg AD. Handbook of human immunology. 2ª ed. Boca Raton: CRC, 2008. p. 257-65. ISBN 978-0-8493-1984-6. CITOMETRIA DE FLUXO; PACIENTES HIV-1; VIRUS DA IMUNODEFICIENCIA HUMANA DO TIPO 1; SINDROME DA IMUNODEFICIENCIA ADQUIRIDA |
| 974/1816 | US=39 / Câncer Vollmers HP, Brändlein S. Sensitization of epithelial cancer cells with human monoclonal antibodies. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 3-11. ISBN 978-1-58829-989-5. CELULAS CANCEROSAS EPITELIAIS; ANTICORPOS MONOCLONAIS HUMANOS; ANTICORPOS NATURAIS IGM; FATOR DE RECEPTORES DE CRESCIMENTO; FATOR DE ACELERACAO DO DECAIMENTO; PROTEINAS DE CHOQUE TERMICO |
| 975/1816 | US=39 / Câncer Daniels TR, Neacato IL, Helguera G, Penichet ML. Targeting the transferrin receptor to overcome resistance to anti-cancer agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 13-27. ISBN 978-1-58829-989-5. RECEPTORES-ALVO; TRANSFERRINA; AGENTES ANTICANCERIGENOS; QUIMIORRESISTENCIA |
| 976/1816 | US=39 / Câncer Bonavida B, Jazirehi AR, Vega MI, Huerta-Yepez S, Umezawa K, Suzuki E. Chemo-immunosensitization of resistant B-NHL as a result of rituximab (anti-CD20 mAb)-mediated inhibition of cell survival signaling pathaways. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 29-39. ISBN 978-1-58829-989-5. SENSIBILIZACAO IMUNITARIO; B-NHL; RITUXIMABE; ANTI-CD20 MAB; SINALIZACAO CELULAR |
| 977/1816 | US=39 / Câncer Yoshida T, Sakai T. Agents that regulate DR5 and sensitivity to TRAIL. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 41-9. ISBN 978-1-58829-989-5. |
| 978/1816 | US=39 / Câncer Motarjemi M, Hallett WHD, Li M, Murphy WJ. Proteasome inhibition: potential for sensitization of immune effector mechanisms in cancer. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 51-60. ISBN 978-1-58829-989-5. INIBICAO DO PROTEASSOMA; SENSIBILIZACAO DE MECANISMOS EFETORES IMUNES; CANCER; BORTEZOMIBE; CDDO |
| 979/1816 | US=39 / Câncer Francia G, Emmenegger U, Kerbel RS. Angiogenesis inhibitors as enabling agents for the chemotherapeutic treatment of metastatic disease. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 63-80. ISBN 978-1-58829-989-5. INIBIDORES DA ANGIOGENESE; TRATAMENTO QUIMIOTERAPEUTICO; DOENCA METASTATICA |
| 980/1816 | US=39 / Câncer McCubrey JA, Franklin RA, Bertrand FE, Taylor JR, Chappell WH, Sokolosky ML, Wong EWT, Abrams SL, Stadelman KM, Misaghian N, Ludwing DL, Basecke J, Libra M, Stivala F, Milella M, Tafuri A, Martelli AM, Lunghi P, Bonati A, Terrian DM, Lehmann BD, Steelman LS. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK and PI3K/Akt pathways to sensitize cancer cells to therapy. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 81-114. ISBN 978-1-58829-989-5. SEGMENTACAO CASCATAS DE SOBREVIVENCIA; ATIVACAO DE RAS / RAF / MEK / ERK; VIAS PI3K/AKT; SENSIBILIZACAO DAS CELULAS CANCEROSAS; APOPTOSE; CANCER HEMATOPOIETICO |